THERALLO
LIVE

Serial Number

99472514

Owner

THERALLO

Attorney

Pina Campagna

Filing Date

Oct 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

THERALLO Trademark

Serial Number: 99472514 • Registration: 8282142

THERALLO is a trademark filed by THERALLO on October 31, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

THERALLO

470 Promenade des Anglais
Nice 06000 , FR

Entity Type: 99

Trademark Details

Filing Date

October 31, 2025

Registration Date

June 2, 2026

Published for Opposition

April 14, 2026

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatories; Pharmaceutical preparations for activating cell function for medical purposes; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Biochemical reagents for medical or veterinary purposes; Biological tissue cultures for medical purposes; Stem cells for medical purposes; Cell culture media for medical purposes

Research and development in the field of allogeneic and autologous molecular and cell therapies; Scientific and technological services, namely, research and design in the field of allogeneic and autologous molecular and cell therapies; Medical research services; Pharmaceutical research services; Research and development in the field of stem cells, cell and gene therapy and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing scientific research information in the field of stem cells, cell and gene therapy and biotechnology; Scientific study and research in the field(s) of molecular and allogeneic or autologous cell therapy; Providing medical and scientific research information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
ASSIGNED TO EXAMINER
Apr 24, 2026 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 16, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 31, 2025 MAFR
NEW APPLICATION ENTERED
Oct 31, 2025 NWAP